Skip to main content

Day: December 30, 2019

Sify Technologies recognized as a ‘Major Player’ in Managed Cloud Services

Santa Clara, California, Dec. 30, 2019 (GLOBE NEWSWIRE) —Sify Technologies Limited (NASDAQ: SIFY), headquartered at Chennai, India, India’s most comprehensive ICT solutions provider with global service capabilities spanning domestic and international Telecom Networks, Data Centers, Cloud, Applications, Managed Services and Systems integration, has been recognized as a ‘Major Player’ in Managed Cloud services by the IDC MarketScape. The recognition has been published in IDC MarketScape: Asia/Pacific (ex. Japan) Managed Cloud Services (MCS) 2019 Vendor Assessment.With its “cloud@core” strategy, Sify helps Enterprises pursue their goal of architecting and migrating workloads to any cloud. It offers hosted Enterprise applications ‘as-a-Service’ for SAP, Oracle Exadata, Azure Stack, and high-performance...

Continue reading

Tauriga Sciences, Inc. Commences Development of Cannabigerol “CBG” Isolate Infused Version of Tauri-Gum

Flavor: Starfruit/PeachNEW YORK, NY, Dec. 30, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced it has commenced development of a Cannabigerol (“CBG”) Isolate Infused version of its flagship brand and product line: Tauri-Gum™. The Company expects that each tablet of chewing gum will contain 10mg of CBG Isolate. The flavor (all natural) selected for this CBG Infused version of Tauri-Gum™ will be Starfruit/Peach. This product will also be Kosher Certified (Star-K), Vegan, and 100% Made in the...

Continue reading

VERUS INTERNATIONAL ENGAGES TOP TEN NATIONAL PUBLIC ACCOUNTING FIRM

Gaithersburg, MD, Dec. 30, 2019 (GLOBE NEWSWIRE) — Verus International, Inc. (“Verus” or the “Company”) (OTCQB: VRUS) announced today that it has engaged CBIZ Mayer Hoffman McCann, LLC (“CBIZ MHM”) as the Company’s new independent registered public accounting firm. Mayer Hoffman McCann P.C. (“MHM”) will provide all attest services, including audit and review services, and CBIZ will provide all non-attest services, including consulting, tax, and advisory services. CBIZ MHM is the financial services division of CBIZ, Inc., and is one of the top ten accounting providers in the United States with over 2,000 professionals nationwide in over 30 offices.“Engaging a top-tier national public accounting firm will provide investors and financial partners with an added measure of...

Continue reading

VSBLTY AND PURE INTEGRATIVE PHARMACY LAUNCH PILOT PROGRAM TO EDUCATE CONSUMERS TO TAKE CONTROL OF THEIR OWN HEALTH

Philadelphia, PA, Dec. 30, 2019 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC:VSBGF) (“VSBLTY”), a leading retail software technology company, and Pure Integrative Pharmacy, the Vancouver-based firm with 16 pharmacies throughout British Columbia in Canada, today announced a pilot program to educate consumers about the specific cutting-edge vitamins and supplements that will help them take control of their own health and enjoy greater vitality, safely and sustainably. Pure Integrative Pharmacy is part of Overwaitea Food Group, a major grocery chain operator, which already has more than 160 stores in western Canada under the Save-On-Foods banner, among others.VSBLTY technology provides enhanced customer engagement and audience measurement using machine learning...

Continue reading

Teleflex to Present at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top

WAYNE, Pa., Dec. 30, 2019 (GLOBE NEWSWIRE) — Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top conference at the Goldman Sachs Office in New York, NY, on Thursday, January 9, 2020 at 2:50 p.m. (ET). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at www.teleflex.com. About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse,...

Continue reading

ALM Equitys dotterbolag Småa säljer utvecklat tomtområde i Uppsala till Obos

2019-12-30ALM Equitys dotterbolag Småa AB har utvecklat 38 nya bostads- och skoltomter i området Skölsta, Uppsala. Fastigheten bestod initialt av cirka 82 tomter, varav 10 såldes 2016, 38 avyttras nu och resterande planerade cirka 34 behålls tills vidare.De 38 tillskapade fastigheterna avyttras till bostadsutvecklaren OBOS. Värdet på fastigheterna vid försäljningen uppgår till 55 Mkr.Den ursprungliga fastigheten förvärvades i juni 2016 via bolaget Arosslätten 2 AB.”Genom att driva detaljplan för området har Småa nu förädlat stora delar av området och ser det som en naturlig del av bolagets strategi att avyttra de färdiga tomterna” säger Joakim Alm, VD ALM Equity AB. Småa AB planerar att tillskapa ytterligare...

Continue reading

NIO Inc. Reports Unaudited Third Quarter 2019 Financial Results

Quarterly Total Revenues reached RMB1,836.8 million (US$257.0 million)Quarterly Deliveries of the ES8 and the ES6 were 4,799 vehiclesSHANGHAI, China, Dec. 30, 2019 (GLOBE NEWSWIRE) — NIO Inc. (“NIO” or the “Company”) (NYSE: NIO), a pioneer in China’s premium electric vehicle market, today announced its unaudited financial results for the third quarter ended September 30, 2019.Deliveries of vehicles were 4,799 in the third quarter of 2019 including 4,196 ES6s and 603 ES8s, compared with 3,553 vehicles delivered in the second quarter of 2019.Financial Highlights for the Third quarter of 2019Vehicle sales were RMB1,733.5 million (US$242.5 million) in the third quarter of 2019, representing an increase of 22.5% from the second quarter of 2019 and an increase of 21.5% from the same quarter of 2018.Vehicle...

Continue reading

Franchise Group, Inc. to Acquire American Freight Group, Inc.

VIRGINIA BEACH, Va., Dec. 30, 2019 (GLOBE NEWSWIRE) — Franchise Group, Inc. (NASDAQ: FRG) (“Franchise Group” or the “Company”), today announced it has entered into a definitive agreement under which it will acquire American Freight Group, Inc. (“American Freight”), a retail chain offering brand-name furniture, mattresses and  home accessories at discount prices, in an all cash transaction valued at approximately $450 million from an affiliate of The Jordan Company, L.P. and other stockholders of American Freight (the “Transaction”).  Upon the closing of the Transaction, Franchise Group’s systemwide revenue, which is defined as total sales for both franchise and company units, will exceed $2.4 billion.The Transaction is expected to be completed in the first quarter of...

Continue reading

Consortium led by Northern Private Capital Signs Definitive Agreement to Acquire MDA, Canada’s Leading Space Technology Company

TORONTO, Dec. 30, 2019 (GLOBE NEWSWIRE) — A consortium led by Northern Private Capital (NPC), a Toronto-based investment firm led by John Risley and Andrew Lapham, announced today it has signed a definitive agreement to acquire MDA from Maxar Technologies (NYSE:MAXR)(TSX:MAXR) for CAD $1 billion.  Upon closing, MDA’s corporate headquarters will return to Canada.Founded in 1969, MDA is Canada’s largest space technology developer and manufacturer, with over 1,900 employees across Canada. Through a strong collaboration and partnership with the Government of Canada that spans several decades, the company has delivered world-leading, iconic technologies such as the Canadarm family of space robotics for the U.S. Space Shuttle program and the International Space Station and three generations of RADARSAT Earth observation...

Continue reading

Axsome Therapeutics Announces AXS-07 Achieves Co-Primary and Key Secondary Endpoints in MOMENTUM Phase 3 Migraine Trial in Patients with History of Inadequate Response

Demonstrated statistical significance on regulatory co-primary endpoints of pain freedom (p<0.001) and freedom from most bothersome symptom (p=0.002) at 2 hours, compared to placeboDemonstrated superiority to rizatriptan active comparator on key secondary endpoint of sustained pain freedom 2-24 hours after dosing (p=0.038)Demonstrated greater and more sustained migraine pain relief than rizatriptan (p=0.006)Rapidly relieved migraine pain; significantly reduced use of rescue medication compared to rizatriptan (p<0.001) Positive results support NDA filing of AXS-07 in the acute treatment of migraine, anticipated in 2H 2020Company to host conference call today at 8:00 AM ETNEW YORK, Dec. 30, 2019 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.